Summary -Even though artificial surfactant is now available, respiratory distress syndrome still remains a serious problem in neonatology. Prenatal analysis of the amniotic fluid can provide data giving insight into the fetal lung maturity, which enables planning of the further outcome of high-risk pregnancies. Surfactant prevents atelectasis by forming a layer rich in phospholipids between the air and liquid phase in alveoli thus leading to increased surface tension in them, which is a precondition for a good lung function after birth. Lamellar bodies are a form of stored surfactant, and their count in the amniotic fluid can be determined simply by a standard hematology analyzer. The method of determining lamellar body count has found an important place in prenatal diagnostics and is recommended as an initial method of a "cascade" procedure of testing fetal lung maturity. However, considering the importance of procedure of sample collection, storage and centrifugation, which can significantly affect the results obtained for the lung maturity, the amniotic fluid samples must be absolutely free of contamination with blood, meconium, mucus, bacteria and leucocytes.
Introduction
Amniotic fluid represents an extracorporeal environment, which has a strong influence on pregnancy outcome. It is a place of dynamic biochemical processes and it also indicates a condition of fetoplacenal unit. The amniotic fluid is developed during active secretions of amniotic epithelium, fluid transudation through maternal blood vessels, fetal kidneys activity and secretions of fetal trachea and bronchi. The volume represents a balance between structures that allow the passage of fluid into the amniotic cavity (the horion frondosum and membranes, the skin, the urinary and respiratory tract) and structures involved in the removal of amniotic fluid (the gastrointestinal tract, the respiratory tract, amniotic-chorionic interface at the uterine wall) [1, 2] .
The composition of amniotic fluid varies with gestational age. The amniotic fluid is composed of water containing proteins, lipids, hormones, prostaglandins, catecholamines, enzymes, electrolytes, glucose, urea, creatinine and bilirubin. Epithelial skin cells, vernix, lanugo hairs, desquamated fetal cells, parts of meconium and urine acid salts can be found in the amniotic fluid by the end of pregnancy. A clinical study of amniotic fluid components and their respective variations provides useful indications of pregnancy and fetal maturity [1, 3] .
Respiratory distress syndrome (RDS) of the newborn is a major cause of morbidity and mortality in infants born preterm. The most frequent cause of RDS is surfactant deficiency, which can be estimated before birth by some tests for determination of surfactant components in the amniotic fluid. The evaluation of phospholipids in the amniotic fluid for the determination of fetal lung maturity (FLM) has been used for more than 30 years. The current "gold standard" for the determinations of FLM is measurement of lecithin/sphingomyelin ratio and quantification of phospholipids. Lamellar bodies, a storage form of surfactant, are secreted by alveolar type II pneumocytes. The similar size of lamellar body to platelet size of 1-5 μm permits the use of an automated hematology cell counter to quantify their number rapidly, easily and inexpensively [4, 5] .
The ways of sample collection, storage and centrifugation can affect results of FLM, therefore laboratory protocols are recommended to be used by some authors [5] [6] [7] .
Clinical sampling of the amniotic fluid can be done by amniocentesis or from the vaginal posterior fornix after premature rupture of the membranes as well as during Cesarean section as it has been stated in some clinical studies [6, 8, 9] .
Material and methods
A prospective clinical study was conducted from April 2005 to March 2006 in which amniotic fluid samples were collected in order to determine a cutoff of the lamellar body count that would best predict fetal lung maturity.
The study was performed on three groups of pregnant women. In the first group of women, the amniotic fluid was collected from the posterior vaginal fornix in preterm rupture of membranes or during delivery after amniotomy. In the second group of women, the amniotic fluid was collected during Cesarean delivery. In the third group consisting of women with clear indications for this kind of sampling, the amniotic fluid was collected by transabdominal late amniocentesis.
During the study the following data were obtained: patient's age, gestational age, personal anamnesis, indications for amniocentesis in high-risk pregnancies.
Exclusion criteria were an uncertain gestational age, fetal anomalies and monoamniotic twin pregnancies.
Samples were collected in 10 ml syringes and analyzed in the laboratory immediately after arrival. Samples contaminated with visible blood, meconium or mucus were excluded. Only turbid amniotic fluid samples were centrifuged for 3 minutes at 500g and then analyzed. The information that the sample had been centrifuged was noted.
To determine the lamellar body count (LBC) it is necessary to have 0.5 ml of the amniotic fluid. All samples should be mixed gently before starting the analy sis, because lamellar bodies settle to the bottom of the collection container. Lamellar bodies are counted by Nihon-Kohden® hematology analyzer by means of the platelet channel, where their count is determined according to the cell volume. The analyzer shows the platelet count result, which is to be multiplied by 1000 in the case of lamellar bodies in order to get lamellar body count in 1 μm of amniotic fluid. The hematology analyzer also shows the presence of white blood cells, red blood cells and hemoglobin, if any. Accordingly, our sample was reported to be contaminated.
Results
To establish the cutoff of LBC, 232 samples of amniotic fluid were tested, out of which 112 (48.3%) were collected by transvaginal amniotomy, 88 (37.9%) during Cesarean delivery and 32 (13.8%) by amniocentesis (in cases when delivery ensued within 72 hours after amniocentesis) (Graph 1).
Of 232 samples, 102 were centrifuged for 3 minutes at 500 g. In 112 (48.3%) samples some kind of contamination was reported. The most frequent contaminator was white blood cells in concentration of 1.2x10³/l to 27.2x10³/l. The most contaminated samples were those collected by vaginal pool, their number being 68 out of 112 (60.7%); contamination was observed in 37 of 88 samples collected during Cesarean delivery (42%). The least contamination was observed in samples collected by amniocentesis, 7 of 32 (21.9%) (Graph 2).
LBC with the cutoff of 42x10³/μl was the best to predict RDS (82.4% sensitivity and 64.6% specificity). The sensitivity and specificity varied in different types of sampling and they are given in Table 1 .
Discussion
In our study 112 amniotic fluid specimens (48.3%) were collected by vaginal pool immediately before delivery, 88 (37.9%) during Cesarean delivery and 65 samples by amniocentesis. The analysis of samples was limited to 32 ones collected by amniocentesis from women who delivered within 72 hours after the sampling. According to the literature data, samples collected by amniocentesis are representative only if collected within 72 hours after the delivery. Therefore it is believed that the test result is not a reliable measure of the actual state of FLM anymore [10] [11] [12] .
It is very important to collect uncontaminated amniotic fluid because samples contaminated with blood, meconium, mucus, bacteria and white blood cells can seriously affect the results of the FLM tests [4, 6] . 
Višnjevac J, i sar. Način uzorkovanja plodove tečnosti 484

Graph 2. Presence of contamination in different sampling groups Grafikon 2. Onečišćenja u uzorku plodove tečnosti
Contamination of a sample with fresh blood resulting in a hematocrit exceeding 1% has the most important influence on the results. The hematology analyzer can not make differences between platelets and lamellar bodies because of similarity of lamellar body size to platelet size. The presence of platelets in samples contaminated with blood can affect the results of FLM in different ways. The final result can represent the sum of these two particles, which increase a number of the false negative results. In case when samples contaminated with blood can not be analyzed soon after the sampling, lamellar bodies and platelets could be trapped in the clot matrix, thus decreasing results and increasing the number of the false positive results. If bloody fluid is evident during amniocentesis, multiple samplings are recommended [4, 6] .
During the fetal life, the fetus swallows amniotic fluid containing lamellar bodies as well, so they can be found in meconium. Meconial contamination of amniotic fluid affects the results, increasing the lamellar body count by approximately 5000/μl [4] .
Samples obviously contaminated with mucus decrease the number of lamellar bodies because they precipitate at the bottom of container. Mucus can affect work of the hematology analyzer, it can be clogged in a vacuum pipette, and therefore specimens containing obvious mucus should not be used [4, 6] .
A group of coliform bacteria can be often found in the genital organs of women and affect test of fetal lung maturity. The most usual coliform bacteria, Escherichia colli, increases the concentration of phosphatidylglycerol. However, their affect on LBC is not known [4] .
The presence of white blood cells in the amniotic fluid usually suggests an amniotic infection in samples collected by amniocentesis, or a cervical or vaginal infection when samples are collected vaginally. White blood cells have proteolityc enzymes, which can affect some surfactant components. However, it is not known for certain whether white blood cells affect the lamellar body count and the accuracy of prediction of the fetal lung maturity. The hematology analyzer recorded contamination of 112 samples (48.3%). Most samples had white blood cells in concentration of 1.2 to 27.2x10 9 /l. Out of 112 samples collected by vaginal pool, 68 (60.7%) had the most contaminators. This result was expected, because the vagina has normal bacteria flora. Therefore, some authors recommend vaginal sampling in patients with prematurely ruptured membranes when amniocentesis could endanger the fetus [6, 9] .
Samples should be analyzed immediately after the sampling when a laboratory is nearby, but if a laboratory is faraway, wet ice transportation is recommended. Cooling of amniotic fluid decreases the enzyme activity, thus damaging phospholipids. When testing must be delayed storage at 4 0 C is appropriate, for long-term studies amniotic fluid can be stored at -20 0 C to -70 0 C [6] .
There are different opinions about the necessity to centrifuge samples. Some authors are against centrifugation because lamellar bodies are very fragile (centrifugation decreases the lamellar body count to 40%) . Ashwoods recommends centrifugation at 400 g for 2 min, with lamellar bodies loss less than 8%. Some authors suggest centrifugation of turbid samples at 276-1000 g for 2-10 minutes because the loss is very small and statistically not significant [6, 11, 14] .
In our study, 102 (44%) visibly contaminated samples were centrifuged at 500g for 3 minutes, that was the slowest speed and the shortest time on the machine in our laboratory.
The analysis provided values of LBC for predicting RDS less than 42x10 3 /μl, with sensitivity of 82.4% and specificity of 64.6%. The samples collected by amniocentesis had the highest sensitivity 86.7% (ability to recognize the positive cases), the least sensitivity was achieved in the group collected by Cesarean delivery. The highest specificity (ability to recognize the negative cases and to exclude the false positive cases) was in the amniocentesis group, the least was 62.7% in the vaginal samples. The results signify that the samples collected by amniocentesis had the lowest percentage of contamination and the best predicted RDS. The vaginal samples were the most contaminated samples of all groups and the number of recognized RDS was the smallest.
Conclusion
Lamellar body count has a great predictive value for fetal lung maturity with high sensitivity and specificity. In clinical work, samples of amniotic fluid can be collected by amniocentesis or from the vaginal posterior fornix after premature rupture of the membranes, and in clinical research, samples can be collected during Cesarean sections. Samples collected by amniocentesis had the lowest percent of contamination and the highest sensitivity and specificity. The presence of contamination in amniotic fluid affects the accuracy of the fetal lung maturity tests.
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